Chiauranib
- Generic Name
- Chiauranib
- Drug Type
- Small Molecule
- Chemical Formula
- C27H21N3O3
- CAS Number
- 1256349-48-0
- Unique Ingredient Identifier
- F40IRN5981
Overview
Chiauranib is under investigation in clinical trial NCT03974243 (Chiauranib in Combination With Chidamide in Patients With Relapsed/refractory Non-hodgkin's Lymphoma).
Background
Chiauranib is under investigation in clinical trial NCT03974243 (Chiauranib in Combination With Chidamide in Patients With Relapsed/refractory Non-hodgkin's Lymphoma).
Indication
用于治疗经过2线系统化疗方案后疾病进展或复发的小细胞肺癌（SCLC）。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath